Blog
RSS FeedPosted by Michael Wonder on 24 Jun 2020
Towards greater impact in health technology assessment: horizon scanning for new and emerging technologies in Singapore
22 June 2020 - To alert policy makers early about emerging health technologies that could significantly impact the healthcare system at ...
Posted by Michael Wonder on 26 May 2020
Superb health care at ultra low prices? How Singapore does it
26 May 2020 - Can you imagine the United States having a health care system that delivers better outcomes than those ...
Posted by Michael Wonder on 03 Dec 2019
Health technology assessment and its use in drug policies: Singapore
2 December 2019 - Singapore has a robust health care system that is well known for delivering good health outcomes. ...
Posted by Michael Wonder on 03 Dec 2019
Puma Biotechnology licensing partner Specialised Therapeutics receives marketing approval in Singapore for Nerlynx (neratinib) for extended adjuvant treatment of early stage hormone receptor positive HER2-positive breast cancer
2 December 2019 - Puma Biotechnology announced that its licensing partner Specialised Therapeutics Asia has received marketing approval of Nerlynx (neratinib) ...
Posted by Michael Wonder on 13 Nov 2019
FDA’s Project Orbis may expand to Singapore and Switzerland
12 November 2019 - The US FDA may expand a pilot project that allows for simultaneous drug approval decisions from ...
Posted by Michael Wonder on 12 Nov 2019
Rare Disease Fund now covers Pompe disease, a rare inherited neuromuscular disorder
3 November 2019 - The Rare Disease Fund now covers Singaporeans with Pompe disease - a rare inherited neuromuscular disorder ...
Posted by Michael Wonder on 03 Jul 2019
New hope for patients with rare diseases with the launching of a new fund
2 July 2019 - Singaporeans with three forms of rare diseases now have access to financial aid to help with ...
Posted by Michael Wonder on 19 Feb 2019
New early breast cancer drug to be made available in Singapore via Special Access Program
17 February 2019 - Subsidised Singapore Special Access Program open today to patients with HER2-over-expressing cancers. ...
Posted by Michael Wonder on 05 Jul 2018
International work-sharing pilot - apalutamide (Erlyand)
5 July 2018 - Apalutamide (Erlyand) is the first medicine to be registered on the Australian Register of Therapeutic Goods ...
Posted by Michael Wonder on 17 Apr 2018
ACSS - NCE work-sharing pilot
17 April 2018 - The ACSS Consortium is a collaborative initiative of like-minded, medium-sized regulatory authorities between Australia's Therapeutic Goods Administration, ...
Posted by Michael Wonder on 03 Oct 2017
What makes Singapore’s health care so cheap?
2 October 2017 - Singapore’s health care system is distinctive, and not just because of the improbability that it’s admired ...